Abstract-Campylobacter is the leading causes of bacterial foodborne illness in humans and is associated with poultry consumption. Currently there are no effective treatments to eliminate Campylobacter from poultry. Extracts from the American Cranberry (Vaccinium macrocarpon) containing proanthocyanidins have inhibited other foodborne pathogens. In this study, we evaluated two different cranberry extracts, either containing low (1%, L-PAC) or high concentrations (30%, H-PAC) of proanthocyanidins, to reduce Campylobacter counts, in vitro or in vivo. Although effective in vitro, when fed to 70 day-of-hatch birds at either 0% (control), L-PAC (0.5%, 1% or 2%) or H-PAC (0.5%, 1% or 2%) in replicate trials, Campylobacter counts were not reduced. Although highly effective in vitro, further evaluation is needed to determine optimum concentrations of cranberry proanthocyanidins to reduce Campylobacter in poultry.
I. INTRODUCTION
One of the leading bacterial causes of food borne illness worldwide is contamination of food products with Campylobacter spp. [1] . Estimates of food borne illness attributed to Campylobacter, based on data collected from the Centers for Disease Control (CDC), put the rate at approximately 850,000 cases per year [2] . Epidemiological studies have indicated that the most frequent routes for human infection with Campylobacter are eating improperly cooked chicken, handling chicken and exposure to animals including poultry [1] . Campylobacter is a commensal in chickens, naturally colonizes in the lower intestine, preferentially in the crypts within the ceca, where they are able to reach levels as high as 10 6 -10 8 cfu/gram of cecal material [3] . The prevalence of Campylobacter spp. within poultry flocks in the United States is reported to be as high as 90% [4] . The Food Safety and Inspection Service has estimated the percent of chicken carcasses positive for Campylobacter in the processing plant to be approximately 46%, which can be attributed to the feathers, the skin and the gastrointestinal tract having a high Campylobacter load which cannot be completely eliminated during processing [5] , [6] . High levels of Campylobacter on and in the bird Manuscript received November 9, 2015; revised February 19, 2016. at the time of slaughter have a significant impact on carcass contamination; so a reduction of Campylobacter in poultry pre-harvest should lead to a reduction in human campylobacteriosis cases from contaminated poultry products [7] , [8] . Multiple strategies have been tried to reduce Campylobacter colonization in poultry with limited success and additional treatments need to be developed to reduce this food borne pathogen in poultry [9] .
Renewed interest has been placed on plant extracts for the control of pathogens in food animals due in part to restrictions by the U.S. Food and Drug Administration (FDA) on antibiotic usage in livestock production. This challenges food animal producers to find alternatives to antibiotics and still maintain animal health and welfare [10] . Alternatives to antibiotics may come from phytogenics, or plant derived compounds, some of which have the benefit of being designated as Generally Recognized as Safe (GRAS) by FDA. Compounds with GRAS designation as deemed safe to be used in foods and require no lengthy approval process, which allows them to adopted for use quickly (Code of Federal Regulation 21CFR 184. 1025, 1981) . Plant extracts from the American Cranberry (Vaccinium macrocarpon) are GRAS and have many bioactive compounds, some of which demonstrate antimicrobial activity [11] - [16] . Cranberry extract has documented in vitro antibacterial activity to the food borne pathogens E.coli O157:H7, Salmonella Typhimuium, and Listeria monocytogenes [14] , [17] .
To our knowledge, cranberry extracts have not been evaluated for their ability to reduce Campylobacter in poultry. For this study two commercially available GRAS designated cranberry extracts were tested. These extracts are standardized to contain a lower (1%) or higher concentration (30%) of proanthocyanidins by the manufacturer (L-PAC or H-PAC, respectively). The aim of this research was to determine if cranberry extracts, L-PAC and H-PAC, are inhibitory to Campylobacter jejuni, in vitro and if efficacious, examine their potential for use in young chickens to prevent Campylobacter colonization.
II. MATERIALS AND METHODS

A. Cranberry Plant Extracts
Two extracts of the North American Cranberry (Vaccinium macrocarpon) were used for both the in vitro and in vivo trials; (1) cranberry concentrate powder standardized to contain 1% proanthocyanidins (L-PAC) and (2) dried cranberry extract powder standardized to contain 30% proanthocyanidins (H-PAC) obtained from Decas Botanical Synergies (Carver, MA).
B. In Vitro Antimicrobial Activity of Cranberry Extracts
Assessment of in vitro antimicrobial activity was determined using a mixture of three wild type Campylobacter jejuni strains previously isolated and identified from poultry. Campylobacter inoculum was prepared as previously described by Aguiar and coworkers [18] . For each assay, duplicate samples were tested which included eleven treatments, a positive control (no cranberry extract) and five concentrations (4%, 2%, 1%, 0.5% or 0.1%) of each cranberry extract. Each assay was replicated two times. To prepare the various concentrations of cranberry extract, 900µL of fresh CEB was aliquoted into sterile test tubes and appropriate weights of L-PAC and H-PAC were added to the CEB and resuspended by vortexing. A 100µL aliquot of the three strain C. jejuni culture was inoculated into each cranberry extract tube and a positive control tube (no cranberry extract). Broth cultures were then incubated at 42°C under microaerophilic conditions and samples were taken at 8 hours or 24 hours post-inoculation. A 100 µL sample of each of the C. jejuni plus cranberry extracts was serially diluted (1:10) in Butterfield's Phosphate Diluent (BPD) and direct plated onto Campy-Line Agar (CLA) [19] then incubated at 42°C under microaerophilic conditions for 48 hours. Presumptive Campylobacter colonies were directly enumerated and converted to cfu/mL of broth culture. Bacterial colonies were confirmed by latex agglutination test (PANBIO Inc., Columbia, MD) and by API Campy (Biomeriuex Durham, NC).
C. Animal Studies
Day of hatch broiler chicks was obtained from a commercial hatchery. Birds were weighed individually, placed in floor pens and provided free access to feed and water during the entire duration of the trials. For each trial, 70 chicks were randomly assigned to one of seven treatment groups (n=10 per treatment group). Treatment groups for each trial included a positive Campylobacter control (no cranberry extract) or 0.5%, 1%, or 2% of either H-PAC or L-PAC added to the feed. The same dosages were used for Trial 2. For each trial, all birds were given feed supplemented with H-PAC and L-PAC, except for positive Campylobacter control, starting at day of placement and continuing through the entire 14 day trial. At day 7 all birds were challenged with a mixture of three wild type Campylobacter jejuni strains by oral gavage. Each bird received 0.25mL of approximately 10 6 cfu/mL Campylobacter jejuni mixture. The Campylobacter challenge was prepared as described by Aguiar and coworkers [18] . On day 14, cecal contents were collected for enumeration of Campylobacter as per the procedure described in our earlier studies [20] . All the birds were individually weighed at the end of the study period and the feed consumption data was also recorded.
D. Statistical Analysis
Data were analyzed using PROC GLM procedure of SAS [21] . Campylobacter counts from the ceca were logarithmically transformed (log cfu/mL) before analysis to achieve homogeneity of variance [22] . Treatment means were partitioned by LSMEANS analysis and probability of P<0.05 was required for statistical significance.
III. RESULTS
A. In Vitro Antibacterial Activity of Cranberry Extracts
There was no consistent reduction (>1 log) in Campylobacter counts for the 0.1 or 0.5% treatments at 8 or 24 hours post-inoculation for either the L-PAC or H-PAC (Table I ) treatments when compared with the controls in either trial. For the 1% treatment, there was at least a one log reduction in Campylobacter counts for both compounds at 8 or 24 hours post dosing for both trials. For the 2 or 4% doses, there was a greater reduction in counts for both time points and trials when compared with control for the L-PAC treatment (Table I) . For H-PAC, the 2 or 4% doses eliminated detectable Campylobacter in both trials (Table I) .
B. Cecal Campylobacter Counts, Body Weights and
Feed Consumption Cecal Campylobacter counts in 14 day old broiler chicks were not reduced by administration of L-PAC or H-PAC in Trial 1 or Trial 2 when compared with the Campylobacter positive control (Table II) .
Body weights were not affected by feeding any dose of L-PAC in either trial when compared with controls (data not shown). Body weights were, however, reduced in Trial 1 at the highest concentration and for the 1% and 2% H-PAC treatments in Trial 2 when compared with controls (data not shown). Although feed consumption was only determined for each pen at the end of the trials,
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©2016 International Journal of Food Engineering the only consistent change for both trials was an increase in feed consumption in the 0.5% H-PAC treated birds versus the controls. Means within columns with no common superscript differ significantly (P<0.05). 1 Chicks were given feed supplement with H-PAC or L-PAC from day of hatch to the end of the 14 day study. At day 7 birds were challenged by oral gavage (0.25mL) with approximately 10 6 cfu/mL of three strains of Campylobacter jejuni in both trials. All Campylobacter data were log10 transformed for statistical analysis.
IV. DISCUSSION
In this study, we evaluated the potential for various doses of two different cranberry extracts, L-PAC and H-PAC, to inhibit the growth of Campylobacter jejuni in broth culture and, if efficacious, to test these compounds for their ability to reduce or eliminate Campylobacter colonization in young broiler chickens. The in vitro antimicrobial susceptibility assays demonstrated that L-PAC and H-PAC at the lowest concentrations had little effect on Campylobacter growth. However the higher concentrations of L-PAC were able to reduce Campylobacter by greater than 5 logs at 8 hours and to undetectable levels 24 hours after treatment. For the H-PAC treatment, at both 8 and 24 hours, Campylobacter was reduced to undetectable levels. These results indicated an apparent dose response relationship between the increasing concentrations of cranberry extracts and increasing efficacy against Campylobacter in vitro. Furthermore, it appears that H-PAC is more effective against Campylobacter than L-PAC in these in vitro trials. H-PAC has a higher concentration of proanthocyanidins than L-PAC which may explain its increased antibacterial activity against Campylobacter. Studies with Proanthocyanidins have shown to have antioxidant and iron scavenging properties [23] - [26] and may play a role in the in vitro anti-Campylobacter activity observed in our study. Although these compounds were effective in vitro, they were not able to consistently reduce cecal Campylobacter counts in young broiler chickens.
It is possible that the inability of these cranberry extracts to reduce Campylobacter in young birds is because it was absorbed prior to reaching the ceca in the lower intestine or did not reach the ceca in concentrations high enough to reduce Campylobacter counts. Although increasing the dose in the feed may be an option, it appears, at least for the higher doses of H-PAC, this extract adversely affected the birds as demonstrated by a reduction in body weights.
It is also known that pH and temperature affect the antioxidant activity of cranberry extracts [14] , [27] , which may not be optimal in birds. Transition through the digestive system of the bird would subject these extracts to drastic changes in pH and the elevated body temperature of the chicken may also be a contributing factor [28] . Another possible reason that these cranberry extracts were not efficacious in vivo may be due to the niche Campylobacter occupies in the intestine. Even if cranberry extracts reached the ceca at high concentrations it is possible that penetration into the crypts within the ceca may not occur. Campylobacter is able to sequester itself deep within the mucous filled crypts of the ceca, due to its chemoattraction to mucin, where it remains protected [3] , [29] - [31] . Previous research from our laboratory observed that even when antibiotic treatment eliminated Campylobacter within other sites along the gastrointestinal tract, the crypts remained colonized [32] .
The ability of Campylobacter to remain protected within the mucous in the crypts may also prevent exposure to the anti-adhesive capabilities of cranberry extracts [33] , [34] . Cranberry proanthocyanidins are able to prevent actin filaments of host cells from rearrangement, which is a mechanism used by some pathogenic bacteria for host cell invasion [35] - [37] . In vitro studies to assess host cell invasion by Campylobacter jejuni have determined that it utilizes adhesions and secreted proteins to alter the actin cytoskeleton leading to membrane 'ruffling' then invasion [38] . The significance of this mechanism is supported by in vivo studies demonstrating that modified strains are unable to produce adhesion proteins are not capable of colonizing chickens [39] , [40] . Therefore, treatments which reduce the mucous crypt concentrations may expose Campylobacter to the anti-pathogenic properties of cranberry extracts. Research with bismuth compounds has demonstrated reductions in mucous viscosity and partial efficacy against Campylobacter colonization of the ceca [41] , [42] . Follow up experiments are planned to evaluate if co-administration of bismuth and cranberry extracts can further reduce cecal Campylobacter colonization.
Cranberry extracts contain many flavinoid compounds including anthocyanins and proanthocyanidins [15] , [43] , [44] . Research into the addition of flavonoids to improve poultry nutrition have shown that gut microbiota plays an essential role in the bioavailability of flavonoids, which require deglycosylation in order to be absorbed in the gut [45] . Iqbal and coworkers [45] were able to isolate and identify three Lactobacillus strains from chicken cecal contents that significantly improved the bioavailability of flavonoids. This presents the opportunity for further study of cranberry extracts plus Lactobacillus strains as a potential pre-harvest intervention for Campylobacter colonization of poultry.
V. CONCLUSION
In conclusion, the two cranberry extracts tested in this study were able to inhibit Campylobacter in vitro but not when tested in young chickens. Follow up experiments are needed to increase the potency of cranberry proanthocyanidins, such as combining them with lactic acid bacteria strains or bismuth compounds, which may reduce C. jejuni coloization in chickens. Further, these compounds may have potential efficacy against this important food borne pathogen in post-harvest poultry as they showed promise in in vitro studies.
